These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 14978230
1. Valproic acid inhibits angiogenesis in vitro and in vivo. Michaelis M, Michaelis UR, Fleming I, Suhan T, Cinatl J, Blaheta RA, Hoffmann K, Kotchetkov R, Busse R, Nau H, Cinatl J. Mol Pharmacol; 2004 Mar; 65(3):520-7. PubMed ID: 14978230 [Abstract] [Full Text] [Related]
2. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Eikel D, Lampen A, Nau H. Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903 [Abstract] [Full Text] [Related]
4. Homocysteine inhibits angiogenesis in vitro and in vivo. Nagai Y, Tasaki H, Takatsu H, Nihei S, Yamashita K, Toyokawa T, Nakashima Y. Biochem Biophys Res Commun; 2001 Mar 02; 281(3):726-31. PubMed ID: 11237718 [Abstract] [Full Text] [Related]
5. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Mehta VB, Zhou Y, Radulescu A, Besner GE. Growth Factors; 2008 Dec 02; 26(6):301-15. PubMed ID: 18925469 [Abstract] [Full Text] [Related]
6. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S. Am J Physiol Endocrinol Metab; 2009 Jun 02; 296(6):E1440-9. PubMed ID: 19351806 [Abstract] [Full Text] [Related]
7. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA. Prostate; 2007 Jul 01; 67(10):1099-110. PubMed ID: 17477369 [Abstract] [Full Text] [Related]
8. Discovery of a benzoxazine derivative promoting angiogenesis in vitro and in vivo. Dong Z, Cheng Y, Zhao J, Su L, Zhao B, Zhang Y, Zhang S, Miao J. J Cell Physiol; 2010 Apr 01; 223(1):202-8. PubMed ID: 20049873 [Abstract] [Full Text] [Related]
9. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. Cho HH, Park HT, Kim YJ, Bae YC, Suh KT, Jung JS. J Cell Biochem; 2005 Oct 15; 96(3):533-42. PubMed ID: 16088945 [Abstract] [Full Text] [Related]
10. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Xiao D, Singh SV. Cancer Res; 2007 Mar 01; 67(5):2239-46. PubMed ID: 17332354 [Abstract] [Full Text] [Related]
11. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Gonzalez C, Corbacho AM, Eiserich JP, Garcia C, Lopez-Barrera F, Morales-Tlalpan V, Barajas-Espinosa A, Diaz-Muñoz M, Rubio R, Lin SH, Martinez de la Escalera G, Clapp C. Endocrinology; 2004 Dec 01; 145(12):5714-22. PubMed ID: 15358675 [Abstract] [Full Text] [Related]
12. Novel function of ascorbic acid as an angiostatic factor. Ashino H, Shimamura M, Nakajima H, Dombou M, Kawanaka S, Oikawa T, Iwaguchi T, Kawashima S. Angiogenesis; 2003 Dec 01; 6(4):259-69. PubMed ID: 15166494 [Abstract] [Full Text] [Related]
13. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ, Wang X, Kachhap SK, Kato Y, Wei Y, Zhang L, Atadja P, Pili R. Cancer Res; 2004 Sep 15; 64(18):6626-34. PubMed ID: 15374977 [Abstract] [Full Text] [Related]
14. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM. Oncol Rep; 2005 Jun 15; 13(6):1139-44. PubMed ID: 15870934 [Abstract] [Full Text] [Related]
15. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis. Voisard R, Krebs R, Baur R, Hombach V. Coron Artery Dis; 2010 Aug 15; 21(5):286-91. PubMed ID: 20508518 [Abstract] [Full Text] [Related]
16. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid. Jones J, Bentas W, Blaheta RA, Makarevic J, Hudak L, Wedel S, Probst M, Jonas D, Juengel E. Int J Mol Med; 2008 Sep 15; 22(3):293-9. PubMed ID: 18698487 [Abstract] [Full Text] [Related]
17. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. Michaud SE, Dussault S, Groleau J, Haddad P, Rivard A. J Mol Cell Cardiol; 2006 Aug 15; 41(2):275-84. PubMed ID: 16806264 [Abstract] [Full Text] [Related]
18. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Rössig L, Li H, Fisslthaler B, Urbich C, Fleming I, Förstermann U, Zeiher AM, Dimmeler S. Circ Res; 2002 Nov 01; 91(9):837-44. PubMed ID: 12411399 [Abstract] [Full Text] [Related]
19. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Polytarchou C, Papadimitriou E. Eur J Pharmacol; 2005 Mar 07; 510(1-2):31-8. PubMed ID: 15740722 [Abstract] [Full Text] [Related]
20. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gümbel H, Doerr HW, Nau H, Cinatl J. Invest Ophthalmol Vis Sci; 2005 Sep 07; 46(9):3451-7. PubMed ID: 16123451 [Abstract] [Full Text] [Related] Page: [Next] [New Search]